Magnaspart

Magnesium aspartate dihydrate, the active ingredient in Magnaspart, is a magnesium supplement presented as an oral dosage form for oral use. It is intended to address magnesium deficiency and to support normal muscle and nerve function in adults.

GNH USA supplies Magnaspart as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides batch‑tested products with full documentation for regulatory review. Products are shipped in secure packaging to maintain stability during transport.

Magnaspart, a magnesium supplement, is used to address conditions related to low magnesium status.

- Magnesium deficiency: helps restore adequate magnesium levels in the body. - Muscle function: supports normal muscle contraction and relaxation. - Nerve function: contributes to normal neuromuscular transmission and nerve excitability.

Magnesium aspartate dihydrate may be associated with the following adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after oral intake. - Abdominal discomfort: mild stomach pain or cramping. - Nausea: feeling of unease and urge to vomit. - Flatulence: increased intestinal gas. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium leading to cardiac or neuromuscular issues. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Cardiac arrhythmia: irregular heart rhythm potentially life‑threatening. - Muscle weakness: notable reduction in muscle strength. - Hypotension: unusually low blood pressure. - Respiratory depression: slowed breathing requiring medical attention.

When using Magnaspart, consider the following precautions to ensure safe administration.

- Renal impairment: monitor magnesium levels and adjust use as needed. - Cardiovascular disease: use with caution due to potential effects on heart rhythm. - Concomitant laxative therapy: may increase magnesium absorption and risk of excess. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Drug interactions: review all concomitant medications for possible magnesium‑related effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Magnaspart can interact with certain medicines; awareness of these interactions helps manage therapy.

Major Interactions (Avoid): - Calcium carbonate supplements: may reduce magnesium absorption. - Antacids containing aluminum or magnesium: risk of excessive magnesium intake. - Loop diuretics (e.g., furosemide): increase renal magnesium loss.

Moderate Interactions (Monitor Closely): - Bisphosphonates: may have reduced efficacy when taken with magnesium. - Penicillamine: can chelate magnesium, decreasing its availability. - Proton pump inhibitors: may contribute to low magnesium levels over long‑term use.